Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6) March 30, 2020 No Comments Read More »
Psychosocial aspects and contributions of behavioural science to medication-taking for adults with type 2 diabetes March 15, 2020 No Comments Read More »
A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy February 1, 2020 No Comments Read More »
When patient-reported experience does not match change in clinical outcomes: A perplexing view from the inside of a diabetes distress intervention January 11, 2020 No Comments Read More »
Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis December 11, 2019 No Comments Read More »
Hypoglycemic Confidence in the Partners of Adults with Type 1 Diabetes November 8, 2019 No Comments Read More »
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations October 7, 2019 No Comments Read More »
Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial August 15, 2019 No Comments Read More »
There is value in treating elevated levels of diabetes distress: the clinical impact of targeted interventions in adults with Type 1 diabetes August 5, 2019 No Comments Read More »
